6
Oct
2026
Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026
stand 18C59
14
Dec
2026
Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia
14 Dec 2026 - 16 Dec 2026
stand H1.E10

Medical Union Pharmaceuticals

About Medical Union Pharmaceuticals

Medical Union Pharmaceuticals (MUP) is one of Egypt’s leading pharmaceutical companies and an established force in the Middle East. Founded in 1984, MUP has evolved into an internationally focused pharmaceutical organization with a distinctive portfolio spanning a wide range of therapeutic areas. In 2014, MUP acquired Eli Lilly’s biological manufacturing facility in Egypt, followed by the acquisition of UP Pharma in 2024. Today, MUP exports to 50+ countries across the Middle East, Africa, Latin America, Eastern Europe and CIS, with around 2,500 employees worldwide and revenues of EGP 7.497 billion in 2025.

Meet us at

  • CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
    stand 18C59
  • CPHI Middle East 2026

    Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia
    14 Dec 2026 - 16 Dec 2026
    stand H1.E10
  • Country/Region:
    Egypt
  • On CPHI since:
    2020
  • Certificates:
    1
  • Employees:
    1000 - 4999
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)
Contact info
  • 36 Dr. Mohamed Hasan Al Gamal, 6th District, Nasar City, 11471, Cairo, Egypt

Products from Medical Union Pharmaceuticals (10)

  • Insulinaegypt

    Product Insulinaegypt

    Active ingredient: Insulin human injection 
    Indication: Hypoglycemic Agent 

    Forms:    Vails & Cartilages

    Doses:   Insulinagypt N 100 IU
                   Insulinagypt R 100 IU ...
  • Davalindi Range

    Product Davalindi Range

    Active ingredient:  Cholecalciferol (Vit. D3) 
    Indication: Vit. D3 supplement, treatment of rickets and osteoporosis 


    Forms: Tablet                       I.M. Injection
          ...
  • Dexamethasone

    Product Dexamethasone

    Active ingredient: 8 mg Dexamethasone Phosphat / 2 ml Amp.        

    Indication: Systemic Corticosteroid 


    Forms: Ampoule
  • Levanic

    Product Levanic

    Active ingredient:  Levofluxacin

    Indication: Broad-Spectrum Antibiotic ( Quinolone Group )


    Forms: Levanic 500 mg Tablet
                Levanic 750 mg Tablet
  • Mobitil

    Product Mobitil

    Active ingredient: Meloxicam 

    Indication: Non steroidal Anti-inflammatory, analgesic 


    Forms: Tab, Amp and suppositories 


    Doses:  Mobitil  15 mg Supp, Mobitil  7.5mg Tab, Mobitil  15 mg Tab, Mobitil  15 mg Ampoule
  • Pantoloc Tablet

    Product Pantoloc Tablet

    Active ingredient:  Pantoprazole ( as Pantoprazole Sodium Sesquihydrate)
    Indication: Treatment of reflux oesophagitis, gastric & duodenal ulcers, Zollinger - Ellison Syndrome


    Forms: Pantoloc  20 mg Tablet
                &n...
  • Silvirburn

    Product Silvirburn

    Active ingredient: 10 mg Silver sulfadiazine / 1 gm 

    Indication: For prophylaxis and treatment of infection in burn wounds   


    Forms: Cream and Aerosol 
  • Unictam

    Product Unictam

    Active ingredient: Ampicillin  Sulbactam

    Indication: Upper Respiratory tract infections and Lower respiratory tract infections 


    Forms: Vial, Tab and Suspension 


    Doses: Unictam Vail 375 mg
                 Unictam V...
  • Vidrop

    Product Vidrop

    Active ingredient: 1 Drop = 100 I.U.Vit D3 (Colecalciferol)
    Indication: Vit. D3 supplement, treatment of rickets and osteoporosis


    Forms: Oral Drpos 

  • Xoraxon

    Product Xoraxon

    Active ingredient: Ceftriaxone Sodium

    Indication: Lower RT inf., Acute Bacterial 


    Forms: Vial


    Doses: Xoraxon Vial 0.5 mg Vial (I/V)
                Xoraxon Vial 1 gm Vial (I/V)
             ...

Medical Union Pharmaceuticals Resources (2)